BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29139025)

  • 21. Laboratory assessment of vitamin K status.
    Card DJ; Gorska R; Harrington DJ
    J Clin Pathol; 2020 Feb; 73(2):70-75. PubMed ID: 31862867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.
    Shapiro AD; Jacobson LJ; Armon ME; Manco-Johnson MJ; Hulac P; Lane PA; Hathaway WE
    J Pediatr; 1986 Oct; 109(4):675-80. PubMed ID: 3761086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin K status in patients with short bowel syndrome.
    Krzyżanowska P; Książyk J; Kocielińska-Kłos M; Banaś E; Kaleta M; Popińska K; Szczapa T; Walkowiak J
    Clin Nutr; 2012 Dec; 31(6):1015-7. PubMed ID: 22633417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review on Vitamin K Deficiency and its Biomarkers: Focus on the Novel Application of PIVKA-II in Clinical Practice.
    Dong R; Wang N; Yang Y; Ma L; Du Q; Zhang W; Tran AH; Jung H; Soh A; Zheng Y; Zheng S
    Clin Lab; 2018 Apr; 64(4):413-424. PubMed ID: 29739078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.
    Greer FR; Marshall SP; Severson RR; Smith DA; Shearer MJ; Pace DG; Joubert PH
    Arch Dis Child; 1998 Oct; 79(4):300-5. PubMed ID: 9875038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitamin K deficiency in patients with CF despite supplementation].
    Krzyzanowska P; Lisowska A; Skorupa W; Pogorzelski A; Kamińska B; Cichy W; Popiel A; Walkowiak J
    Med Wieku Rozwoj; 2010; 14(1):68-72. PubMed ID: 20608431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats.
    Harauchi T; Takano K; Matsuura M; Yoshizaki T
    Jpn J Pharmacol; 1986 Apr; 40(4):491-9. PubMed ID: 3735800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous Vitamin K1 for the Correction of Prolonged Prothrombin Times in Non-Bleeding Critically Ill Patients: A Prospective Observational Study.
    Dahlberg S; Schött U; Eriksson EÄ; Tahirsylaj Y; Schurgers L; Kander T
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mother-infant prothrombin precursor status at birth.
    Bloch CA; Rothberg AD; Bradlow BA
    J Pediatr Gastroenterol Nutr; 1984; 3(1):101-3. PubMed ID: 6694038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route.
    Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M
    Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
    Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
    J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-II assay parameters in breastfed infants in Turkey.
    Uluşahin N; Arsan S; Ertogan F
    Turk J Pediatr; 1996; 38(3):295-300. PubMed ID: 8827897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy.
    Klouwer FCC; Koot BGP; Berendse K; Kemper EM; Ferdinandusse S; Koelfat KVK; Lenicek M; Vaz FM; Engelen M; Jansen PLM; Wanders RJA; Waterham HR; Schaap FG; Poll-The BT
    J Inherit Metab Dis; 2019 Mar; 42(2):303-312. PubMed ID: 30793331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acarboxyprothrombin concentration [corrected] after oral prophylactic vitamin K.
    von Kries R; Kreppel S; Becker A; Tangermann R; Göbel U
    Arch Dis Child; 1987 Sep; 62(9):938-40. PubMed ID: 3435609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional Therapy with Vitamin K
    Kuwabara A; Nagae A; Kitagawa M; Tozawa K; Kumode M; Tanaka K
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(3):278-284. PubMed ID: 32612091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Predictors of Functional Vitamin K Insufficiency in Mothers and Newborns in Uganda.
    Santorino D; Siedner MJ; Mwanga-Amumpaire J; Shearer MJ; Harrington DJ; Wariyar U
    Nutrients; 2015 Oct; 7(10):8545-52. PubMed ID: 26501317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin K deficiency in critical ill patients; a prospective observational study.
    Dahlberg S; Schurgers L; Schött U; Kander T
    J Crit Care; 2019 Feb; 49():105-109. PubMed ID: 30415179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for late neonatal vitamin K deficiency by acarboxyprothrombin in dried blood spots.
    Motohara K; Endo F; Matsuda I
    Arch Dis Child; 1987 Apr; 62(4):370-5. PubMed ID: 3592727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.
    Wyskida K; Żak-Gołąb A; Wajda J; Klein D; Witkowicz J; Ficek R; Rotkegel S; Spiechowicz U; Kocemba Dyczek J; Ciepał J; Olszanecka-Glinianowicz M; Więcek A; Chudek J
    Int Urol Nephrol; 2016 May; 48(5):765-71. PubMed ID: 27000106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns.
    Motohara K; Endo F; Matsuda I
    Lancet; 1985 Aug; 2(8449):242-4. PubMed ID: 2862419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.